Leung J, Chiu H, Taneja R
Br J Cancer. 2025; .
PMID: 40055485
DOI: 10.1038/s41416-025-02961-2.
Noyd D, Izurieta-Pacheco A, Mzikamanda R, Nakiddu N, An D, Souvanlasy B
JCO Glob Oncol. 2025; 11:e2400274.
PMID: 39946668
PMC: 11892615.
DOI: 10.1200/GO-24-00274.
Stolojanu C, Steflea R, Micsescu-Olah A, Alexandra I, Popoiu A, Doros G
Biomedicines. 2025; 12(12.
PMID: 39767755
PMC: 11673503.
DOI: 10.3390/biomedicines12122849.
Wei Y, Deng W, To K, Lam T, Tso W, Chan A
J Cancer Surviv. 2025; .
PMID: 39753896
DOI: 10.1007/s11764-024-01739-4.
Sansom-Daly U, Evans H, Darlington A, Weaver M, Rosenberg A, Wiener L
J Palliat Med. 2024; 27(12):1606-1617.
PMID: 39588678
PMC: 11698666.
DOI: 10.1089/jpm.2024.0141.
Sugar and sugar-sweetened beverages in relation to premature aging in adult survivors of childhood cancer.
Lan T, Wang M, Williams A, Ehrhardt M, Jiang S, Huang I
Br J Cancer. 2024; 131(7):1169-1177.
PMID: 39117799
PMC: 11442914.
DOI: 10.1038/s41416-024-02815-3.
Feasibility, efficacy, and safety of animal-assisted activities with visiting dogs in inpatient pediatric oncology.
Steff K, Grasemann M, Ostermann K, Goretzki S, Rath P, Reinhardt D
World J Pediatr. 2024; 20(9):915-924.
PMID: 39112809
PMC: 11422466.
DOI: 10.1007/s12519-024-00829-8.
Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study.
Williams A, Rodday A, Pei Q, Henderson T, Keller F, Punnett A
J Clin Oncol. 2024; 42(28):3330-3338.
PMID: 39058966
PMC: 11481752.
DOI: 10.1200/JCO.24.00038.
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S, Revon-Riviere G, Grover S, Deyell R, Vanan M, Lewis V
Cancer Med. 2024; 13(3):e7033.
PMID: 38400668
PMC: 10891445.
DOI: 10.1002/cam4.7033.
Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma.
Williams A, Liu W, Ehrhardt M, Mirzaei Salehabadi S, Panoskaltsis-Mortari A, Phillips N
Clin Cancer Res. 2024; 30(9):1822-1832.
PMID: 38381440
PMC: 11062814.
DOI: 10.1158/1078-0432.CCR-23-3709.
Supportive Care in Pediatric Oncology: Opportunities and Future Directions.
Freedman J, Beeler D, Bowers A, Bradford N, Cheung Y, Davies M
Cancers (Basel). 2023; 15(23).
PMID: 38067252
PMC: 10705083.
DOI: 10.3390/cancers15235549.
Acute lymphoblastic leukemia in young adults: which up-front treatment?.
Molina J, Rotz S
Hematology Am Soc Hematol Educ Program. 2023; 2023(1):573-580.
PMID: 38066875
PMC: 10727055.
DOI: 10.1182/hematology.2023000510.
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.
Pearson A, de Rojas T, Karres D, Reaman G, Scobie N, Fox E
J Natl Cancer Inst. 2023; 116(2):200-207.
PMID: 37975877
PMC: 10852613.
DOI: 10.1093/jnci/djad239.
Impact of Cancer Type and Treatment Protocol on Cardiac Function in Pediatric Oncology Patients: An Analysis Utilizing Speckle Tracking, Global Longitudinal Strain, and Myocardial Performance Index.
Ardelean A, Olariu I, Isac R, Nalla A, Jurac R, Stolojanu C
Diagnostics (Basel). 2023; 13(17).
PMID: 37685367
PMC: 10486976.
DOI: 10.3390/diagnostics13172830.
Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century.
Ehrhardt M, Krull K, Bhakta N, Liu Q, Yasui Y, Robison L
Nat Rev Clin Oncol. 2023; 20(10):678-696.
PMID: 37488230
DOI: 10.1038/s41571-023-00802-w.
Children's Oncology Group's 2023 blueprint for research.
Hawkins D, Gore L
Pediatr Blood Cancer. 2023; 70 Suppl 6:e30569.
PMID: 37433635
PMC: 10529891.
DOI: 10.1002/pbc.30569.
Serum-Stable Gold(III) Bisphosphine Complex Induces Mild Mitochondrial Uncoupling and In Vivo Antitumor Potency in Triple Negative Breast Cancer.
Arojojoye A, Olelewe C, Gukathasan S, Kim J, Vekaria H, Parkin S
J Med Chem. 2023; 66(12):7868-7879.
PMID: 37279147
PMC: 10317555.
DOI: 10.1021/acs.jmedchem.3c00238.
Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort.
Dixon S, Liu Q, Chow E, Oeffinger K, Nathan P, Howell R
Lancet. 2023; 401(10386):1447-1457.
PMID: 37030315
PMC: 10149583.
DOI: 10.1016/S0140-6736(22)02471-0.
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.
Moreno L, Dubois S, Glade Bender J, Mauguen A, Bird N, Buenger V
J Clin Oncol. 2023; 41(18):3408-3422.
PMID: 37015036
PMC: 10414747.
DOI: 10.1200/JCO.22.02430.
Rural, Large Town, and Urban Differences in Optimal Subspecialty Follow-up and Survivorship Care Plan Documentation among Childhood Cancer Survivors.
Noyd D, Janitz A, Baker A, Beasley W, Etzold N, Kendrick D
Cancer Epidemiol Biomarkers Prev. 2023; 32(5):634-641.
PMID: 36827210
PMC: 11082834.
DOI: 10.1158/1055-9965.EPI-22-0966.